BMJ, doi: 10.1136/bmj.39555.441944.BE, (Published 20 May 2008)

Research

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

¹ Inserm Unit 780, Cardiovascular Epidemiology Section, Villejuif Cedex, France, ² IFR69, Université Paris-Sud Villejuif Cedex, France, ³ Université René Descartes Paris V, Paris, France, ⁴ University of Glasgow, Division of Cardiovascular and Medical Sciences, Royal Infirmary, Glasgow

Objective To assess the risk of venous thromboembolism in women using hormone replacement therapy by study design, characteristics of the therapy and venous thromboembolism, and clinical background.

Design Systematic review and meta-analysis.

Data sources Medline.

Studies reviewed Eight observational studies and nine randomised controlled trials.

Inclusion criteria Studies on hormone replacement therapy that reported venous thromboembolism.

Review measures Homogeneity between studies was analysed using ² and I² statistics. Overall risk of venous thromboembolism was assessed from a fixed effects or random effects model.

Results Meta-analysis of observational studies showed that oral oestrogen but not transdermal oestrogen increased the risk of venous thromboembolism. Compared with non-users of oestrogen, the odds ratio of first time venous thromboembolism in current users of oral oestrogen was 2.5 (95% confidence interval 1.9 to 3.4) and in current users of transdermal oestrogen was 1.2 (0.9 to 1.7). Past users of oral oestrogen had a similar risk of venous thromboembolism to never users. The risk of venous thromboembolism in women using oral oestrogen was higher in the first year of treatment (4.0, 2.9 to 5.7) compared with treatment for more than one year (2.1, 1.3 to 3.8; P<0.05). No noticeable difference in the risk of venous thromboembolism was observed between unopposed oral oestrogen (2.2, 1.6 to 3.0) and opposed oral oestrogen (2.6, 2.0 to 3.2). Results from nine randomised controlled trials confirmed the increased risk of venous thromboembolism among women using oral oestrogen (2.1, 1.4 to 3.1). The combination of oral oestrogen and thrombogenic mutations or obesity further enhanced the risk of venous thromboembolism, whereas transdermal oestrogen did not seem to confer additional risk in women at high risk of venous thromboembolism.

Conclusion Oral oestrogen increases the risk of venous thromboembolism, especially during the first year of treatment. Transdermal oestrogen may be safer with respect to thrombotic risk. More data are required to investigate differences in risk across the wide variety of hormone regimens, especially the different types of progestogens.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Type of hormone replacement therapy and risk of venous thromboembolism

Helen Roberts
BMJ 2008 336: 1203-1204. [Extract] [Full Text] [PDF]

Measuring inconsistency in meta-analyses

Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, and Douglas G Altman
BMJ 2003 327: 557-560. [Extract] [Full Text] [PDF]

Making decisions about hormone replacement therapy

Janice Rymer, Ruth Wilson, and Karen Ballard
BMJ 2003 326: 322-326. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Brown, S. (2008). Risk of VTE found lower in those using transdermal hormone replacement therapy. Menopause Int 14: 94-95 [Full text]  
• (2008). Hormone Therapy and Risk for Venous Thromboembolism. JWatch General 2008: 3-3 [Full text]  
• Roberts, H. (2008). Type of hormone replacement therapy and risk of venous thromboembolism. BMJ 336: 1203-1204 [Full text]  

Rapid Responses:

Read all Rapid Responses

HRT increases mortality from thrombosis and cancers

Ellen CG Grant
bmj.com, 26 May 2008 [Full text]

Quality of life and use of menopausal hormone therapy

Martina Dören, et al.
bmj.com, 27 May 2008 [Full text]

HRT and prothrombotic state

Filip Konecny
bmj.com, 7 Jun 2008 [Full text]

HRT, quality of life and mortality

Marianne Canonico, et al.
bmj.com, 10 Jun 2008 [Full text]

Concerned women must be immediately informed

Edith Schuligoi
bmj.com, 13 Jun 2008 [Full text]

Concepts of Quality of life

Martina Dören
bmj.com, 23 Jun 2008 [Full text]